Westyn Branch-Elliman1, Kalpana Gupta2, A Rani Elwy3. 1. Department of Medicine, Section of Infectious Diseases, VA Boston Healthcare System, Boston, MA; VA Center for Healthcare Organization and Implementation Research, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA. Electronic address: wbranche@bidmc.harvard.edu. 2. Department of Medicine, Section of Infectious Diseases, VA Boston Healthcare System, Boston, MA; VA Center for Healthcare Organization and Implementation Research, Boston, MA; Department of Medicine, Boston University School of Medicine, Boston, MA. 3. VA Center for Healthcare Organization and Implementation Research, Boston, MA; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI.
Abstract
BACKGROUND: Clinical guidelines support early discontinuation of antimicrobials after cardiac device procedures; however, prolonged courses of antimicrobials are common. METHODS: We conducted semistructured interviews with 13 electrophysiologists representing diverse geographic and clinical settings of care to identify perceived barriers and facilitators to discontinuing postprocedure antimicrobial prophylaxis as part of a formative evaluation prior to implementing a program to improve uptake of guideline recommendations. A directed content analysis approach was used to map responses to the Implementation Outcomes Framework. RESULTS: Data indicated that electrophysiologists were not willing to stop postprocedural antimicrobials, indicating a lack of acceptability of clinical guidelines. Feasibility, fidelity, cost, and appropriateness were also frequently cited. Factors associated with prolonged antimicrobial prescribing included beliefs about lack of harm and possible benefit. There was a strong "cultural inertia" to conform to institutional normative practices. Reasons for conforming ranged from streamlining processes for clinical staff and concerns about being perceived as an "outlier." CONCLUSIONS: Institutional culture and beliefs about consequences of cardiac device infections versus antimicrobial use appeared to be major drivers of current practice. The desire to promote institutional standardization suggests that strategies to enhance implementation of prophylaxis guidelines must include facility-level changes, rather than interventions directed only at individual-providers. Published by Elsevier Inc.
BACKGROUND: Clinical guidelines support early discontinuation of antimicrobials after cardiac device procedures; however, prolonged courses of antimicrobials are common. METHODS: We conducted semistructured interviews with 13 electrophysiologists representing diverse geographic and clinical settings of care to identify perceived barriers and facilitators to discontinuing postprocedure antimicrobial prophylaxis as part of a formative evaluation prior to implementing a program to improve uptake of guideline recommendations. A directed content analysis approach was used to map responses to the Implementation Outcomes Framework. RESULTS: Data indicated that electrophysiologists were not willing to stop postprocedural antimicrobials, indicating a lack of acceptability of clinical guidelines. Feasibility, fidelity, cost, and appropriateness were also frequently cited. Factors associated with prolonged antimicrobial prescribing included beliefs about lack of harm and possible benefit. There was a strong "cultural inertia" to conform to institutional normative practices. Reasons for conforming ranged from streamlining processes for clinical staff and concerns about being perceived as an "outlier." CONCLUSIONS: Institutional culture and beliefs about consequences of cardiac device infections versus antimicrobial use appeared to be major drivers of current practice. The desire to promote institutional standardization suggests that strategies to enhance implementation of prophylaxis guidelines must include facility-level changes, rather than interventions directed only at individual-providers. Published by Elsevier Inc.
Authors: Anuj Basil; Steven A Lubitz; Peter A Noseworthy; Matthew R Reynolds; Howard Gold; David Yassa; Daniel Kramer Journal: JACC Clin Electrophysiol Date: 2017-06
Authors: Preeti Mehrotra; Kalpana Gupta; Judith Strymish; Daniel B Kramer; Anne Lambert-Kerzner; P Michael Ho; Westyn Branch-Elliman Journal: Infect Control Hosp Epidemiol Date: 2017-01-20 Impact factor: 3.254
Authors: Christian D Helfrich; Adam J Rose; Christine W Hartmann; Leti van Bodegom-Vos; Ian D Graham; Suzanne J Wood; Barbara R Majerczyk; Chester B Good; Leonard M Pogach; Sherry L Ball; David H Au; David C Aron Journal: J Eval Clin Pract Date: 2018-01-05 Impact factor: 2.431
Authors: Westyn Branch-Elliman; Steven D Pizer; Elise A Dasinger; Howard S Gold; Hassen Abdulkerim; Amy K Rosen; Martin P Charns; Mary T Hawn; Kamal M F Itani; Hillary J Mull Journal: Antimicrob Resist Infect Control Date: 2019-03-06 Impact factor: 4.887
Authors: Jafar Bakhshaie; James Doorley; Mira Reichman; Ryan Mace; David Laverty; Paul E Matuszewski; A Rani Elwy; Amirreza Fatehi; Lucy C Bowers; Thuan Ly; Ana-Maria Vranceanu Journal: Transl Behav Med Date: 2022-05-26 Impact factor: 3.626
Authors: Robin M E Janssen; Anke J M Oerlemans; Johannes G Van Der Hoeven; Jaap Ten Oever; Jeroen A Schouten; Marlies E J L Hulscher Journal: J Antimicrob Chemother Date: 2022-07-28 Impact factor: 5.758
Authors: Hillary J Mull; Kelly L Stolzmann; Marlena H Shin; Emily Kalver; Marin L Schweizer; Westyn Branch-Elliman Journal: JAMA Netw Open Date: 2020-09-01